FG-3246

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Metastatic Castration-Resistant Prostate Cancer

Drug Information

Target Indication

Metastatic Castration-Resistant Prostate Cancer

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

FGEN

FibroGen, Inc.

Related Pipeline

Pancreatic Cancer Non-resectable

CKD Anemia in Stable Dialysis Patients

Anemia in Chronic Kidney Disease

Chemotherapy Induced Anemia

Chronic Kidney Disease